This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Propranolol
Cheap, generic, non-selective beta-blocker that shuts off the peripheral adrenergic symptoms of stage fright (racing heart, tremor, sweat,…
Aliases (6)
Overview
What is Propranolol?
Propranolol is a non-selective β-adrenergic receptor antagonist (β-blocker), the first beta blocker discovered (Black, 1962, Nobel 1988). It is FDA-approved for hypertension, angina, post-MI, arrhythmias, migraine prophylaxis, essential tremor, hypertrophic subaortic stenosis, and pheochromocytoma.
Key Benefits
Beyond cardiovascular indications, widely used off-label for performance anxiety, social anxiety symptoms (tremor, palpitations), PTSD-related memory reconsolidation, and akathisia. Reduces somatic symptoms of acute anxiety without sedation or cognitive impairment.
Mechanism of Action
Competitively blocks β1 (cardiac) and β2 (vascular, bronchial) adrenergic receptors, reducing heart rate, contractility, and cardiac output, and inhibiting renin release. Crosses the BBB to dampen central noradrenergic signaling underlying anxiety symptoms and memory reconsolidation.
Pharmacokinetics
▸Brand options6 known
StatusPrescription-only (US, EU, UK, AU, CA); not DEA-scheduled
Peptide Interactions
Co-administer at the same time for an additive layer of calm. L-theanine acts on the GABA/glutamate axis (some α-wave / mild GABA-A modulation, glutamate buf…
Propranolol works best as a backstop for a well-rehearsed, well-prepared event. It doesn't substitute for prep — it lets your prep show through without somat…
Vagal-tone shift adds to the parasympathetic effect.
Armodafinil is a moderate CYP2C19 inhibitor and a weak CYP1A2 inducer. Propranolol is metabolized via CYP2D6 (primary) and CYP1A2 + CYP2C19 (secondary). Net …
Same logic, slightly weaker effect. Same dose-down rule advisable.
redundant.
additive bradycardia and AV-conduction depression. Not relevant for users in this archetype but a hospital-emergency-department flag.
additive bradycardia and rebound-hypertension complication if either is withdrawn. Not relevant.
theoretical risk, rare clinical issue.
peripheral vasoconstriction additive.
(not relevant to the user) — masks hypoglycemia symptoms.
additive hypotension; mild. Not relevant for users in this archetype (zero alcohol).
Quality Indicators
Pharmacy-dispensed, intact packaging
Prescription tablets in original sealed packaging from a licensed pharmacy.
Generic vs branded
Generics are usually fine but bioavailability can vary slightly; track if you switch.
Unbranded blister or counterfeit risk
Counterfeit pharmaceuticals are a known issue; verify pharmacy and lot if buying internationally.
What to Expect
- Day 1PK-driven acute peak per administration. Verify dose tolerated.
- Week 1Steady-state reached for most daily-dosed pharma.
- Week 2-4Therapeutic effect established; titration window if needed.
- Long-termPeriodic monitoring per drug class (labs, BP, ECG as applicable).
Side Effects & Safety 8
Side Effects
- 1Bradycardia / low pulse — expected pharmacodynamic effect. At PRN 20 mg in a healthy 20-year-old, HR drop is ~5-15 bpm. If resting HR is already <50 bpm, dose down or skip.
- 2Cold extremities — reduced peripheral perfusion. Hands/feet feel cold or tingly. Usually mild and self-limiting.
- 3Mild fatigue / lethargy at higher chronic doses (uncommon at PRN doses).
- 4Dizziness / lightheadedness — usually positional; resolves with hydration and avoiding rapid postural change.
- 5Nausea / GI upset — take with food.
- 6Bronchospasm — relevant to anyone with asthma history. Propranolol's β2 blockade can trigger bronchoconstriction. Asthmatics should use β1-selective alternatives (metoprolol, atenolol) instead, or avoid beta-blockers entirely.
- 7Vivid dreams / nightmares — small minority of chronic users report this. Mechanism unclear (possibly REM-architecture effects from CNS penetration). Rare at PRN dosing.
- 8Erectile dysfunction at chronic dose — uncommon; not relevant to PRN single-event use.
When to Stop
- Severe bradycardia or AV block — particularly relevant if the user has pre-existing conduction disease. ECG screening before chronic use, not before a single PRN trial dose.
- Bronchospasm in undiagnosed asthma — first-dose risk. The reason for a low-stakes test dose first.
- Hypoglycemia masking — propranolol blunts the adrenergic warning signs of low blood sugar (tachycardia, tremor) so a hypoglycemic episode can become severe before being recognized. Relevant for diabetics on insulin/sulfonylureas. Not relevant for users in this archetype.
- Withdrawal rebound — abrupt cessation after chronic high-dose use can produce rebound tachycardia, hypertension, and (theoretically) MI in cardiac patients. Not relevant to PRN use; relevant if the user ever migrates to chronic dosing.
- Depression / psychiatric effects — older literature suggested chronic high-dose propranolol increases depression risk. More recent meta-analyses (Riemer et al. 2021) show minimal-to-no effect on mood in non-cardiac populations. Probably an over-stated risk; still worth knowing.
- First test dose: confirm no bronchospasm, no excessive bradycardia. Have a plan to abort if the response is unexpected (rest, hydrate, wait it out — propranolol is competitively reversible and short-half-life).
- First training/cardio day after exposure — verify the workout feel. If you tested propranolol on a Friday evening and your Saturday morning training feels notably worse, that's a sign the half-life carried over more than expected; space the next dose further from cardio events.
- Max HR cap. β1 blockade prevents the heart from achieving full sympathetic-driven max HR. For aerobic athletes, this cuts ~15-30 bpm off max HR and proportionally reduces cardiac output and VO2max during the dose window. For MMA conditioning (rounds, training, intervals), this is a real performance hit — you'll feel like the gas tank is half-size.
- Lactate clearance. Less well-characterized but β2 blockade impairs muscle glycogenolysis and possibly fat mobilization, which can shorten time-to-fatigue at moderate-to-high intensity.
- Thermoregulation. Reduced peripheral blood flow under propranolol = slightly impaired heat dissipation in hot training environments.
- Practical rule for users in this archetype: do not dose propranolol on any day with cardio training, hard pad work, or interval conditioning. PRN propranolol is compatible with technical drilling / light flow / rolling, not with full-output conditioning.
References
Brantigan, Brantigan & Joseph 1982 — Effect of beta-blockade on stage fright (American Journal of Medicine)
classical RCT, 29 musicians; propranolol improves performance + reduces somatic symptoms
View StudyBrunet et al. 2008 — Effect of post-retrieval propranolol on PTSD reactions (J Psychiatr Res)
original reconsolidation protocol
View StudyBrunet et al. 2018 — Reduction of PTSD symptoms with propranolol-induced reconsolidation blockade RCT (Am J Psychiatry)
n=60 chronic PTSD, large effect size, sustained at 4-month follow-up
View StudyRoullet et al. 2021 — Reactivation under propranolol meta-analysis
pooled reconsolidation literature
View StudySoeter & Kindt 2015 — Disrupting reconsolidation: pharmacological and behavioral manipulations (Biological Psychiatry)
phobia reconsolidation work
View StudyPitman et al. 2002 — Propranolol post-trauma for PTSD prophylaxis (Biol Psychiatry)
initial positive ED-trauma study (later non-replicated at scale)
View StudyStein et al. 2007 — Hydrocortisone and propranolol for PTSD prevention RCT
null replication for acute trauma prophylaxis
View StudyHoge et al. 2012 — Propranolol for acute PTSD prevention RCT
null replication
View StudyRiemer et al. 2021 — Beta-blockers and depression meta-analysis (Lancet Psychiatry equivalent)
debunks legacy depression-risk overstatement
View StudyWood et al. 2024 — Propranolol-assisted reconsolidation in moral injury veterans
recent extension trial (2024)
View StudyThierrée et al. 2025 — Reconsolidation in IPV survivors
recent extension trial (2025)
View StudyDrugs.com — Propranolol full prescribing information
dosing, side effects, interactions reference
View StudyPMC — Propranolol pharmacokinetics review (PMID 9456064)
minimal cognitive effects in healthy volunteers
View StudyPsychiatricTimes — Propranolol for performance anxiety clinical use
clinical reference
View StudyHow was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.